According to a media release issued on Tuesday this week by miR Scientific, the US Food and Drug Administration (FDA) has issued a Breakthrough Device Designation for the company’s new urine-based test for risk of prostate cancer (the miR Sentinel™ Prostate Test). … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: miR Sentinel, risk, test, urine | 2 Comments »
Earlier this year, at the annual Genitourinary Cancer symposium in San Francisco, we were first given information about the potential of three new tests for the diagnosis of prostate cancer: the so-called miR Sentinel tests from miR Scientific. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, exome, miR, sentinel, test, urine | 9 Comments »
A newly published article in BJU International has described a way to test post-DRE urine samples for the presence of specific types of ribonucleic acid (RNA) and use these data to detect and classify risk levels for more and less aggressive forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, prognosis, PUR, risk. classification, test, urine | 4 Comments »
Yet another research group is presenting data this week (at a meeting of the American Chemical Society) on the potential to identify risk for prostate cancer based on smell. … READ MORE ….
Filed under: Diagnosis, Risk | Tagged: Diagnosis, risk, small, test, urine | 7 Comments »
Back in April this year we reported on the publication of an article in JAMA Oncology that gave information about the development of a new test for risk of clinically significant prostate cancer — a test that could be conducted using a simple urine sample. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: "high risk", biopsy, ExoDx, risk, test, urine | 14 Comments »
Apparently a newly developed type of urine test — an RNA-based “urine exosome gene expression assay” — has the potential to differentiate between risk for high-grade prostate cancer (Gleason score ≥ 7) and low-grade prostate cancer (Gleason score 6) or benign disease. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: biopsy, Diagnosis, exsome, grade, risk, test, urine | 4 Comments »
A report on the Medscape Oncology site on Tuesday discussed prostate cancer detection data presented at the annual meeting of the American Urological Association (AUA) by a group of Italian researchers — with the help of two highly trained German Shepherds. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, dog, risk, screening, smell, urine | 3 Comments »
For those of you who remember media reports and scientific papers showing that some cancers (prostate cancer included) could be detected, albeit with limited consistency, in urine samples by trained dogs … yes, this is now getting closer to real. … READ MORE …
Filed under: Diagnosis, Management | Tagged: Diagnosis, eNose, smell, urine | 3 Comments »
A new report giving preliminary data on the clinical performance of novel, urine-based prostate cancer assay uses a method known as prostate-specific antigen/solvent interaction analysis (PSA/SIA) to detect the ratios of different types of PSA (PSA “isoforms”) in the urine of men beleived to be at risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: biopsy, Diagnosis, isoform, PSA, PSA/SIA, risk, solvent, urine | 2 Comments »
So the presentation from the AUA yesterday that has already garnered media attention is the idea that we may be able to train dogs to detect prostate cancer based on the aroma of male urine. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, dog, smell, urine | 5 Comments »
A report from the British Broadcasting Corporation this morning says, “Scientists found that in patients with prostate cancer exosomes contain molecules that come directly from the tumour itself.” These particular “exosomes” are fatty capsules that are flushed out of the body in the urine. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: exosomes, risk, test, urine | Leave a comment »
